Announcement of the Listing Notice of Zhongyuan Biotech

• Date：2021-04-29

• By：Zhong Yuan Biotech

To all the shareholders and partners of Zhongyuan Biotechnology holding Group: 

On September 6th, 2019, Zhongyuan Biotech has completed all IPO application documents and the procedures required by the SEC (US Securities and Exchange Commission). The stock code will be obtained after passing the SEC review and the US Financial Regulatory Agency (FINRA) approval.

Thanks for the efforts of all my colleagues in the company and the help and support of partners of ZYB, we will go all out to present a sustainable increase in performance and a satisfying share price for all the shareholders!

Friends who are concerned about our growth can use the "6-K" document published by the SEC to learn more about the company structure, main business sections, and financial status of Zhongyuan Biotech respectively. All documents submitted by the company have been strictly reviewed by international lawyers, auditors, and accountants to ensure that the submitted materials are true and correct. The signature of the international audit firm is as follows:

Thank you again for your support and growth with us, let's create a greater achievement together in the future!